Overview

Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This phase II trial aimed to assess the efficacy and safety of pemetrexed in patients with pretreated metastatic gastric cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Pemetrexed